About us
Bioceres develops crop productivity solutions, including patented seed technologies.

Bioceres Crop Solutions provides crop productivity solutions, including patented technologies for seeds and microbial ag-inputs and crop nutrition and protection.
investors.biocerescrops.comCrawled Oct 26, 2026
Bioceres develops crop productivity solutions, including patented seed technologies.
Bioceres Crop Solutions reports **$53.8 million in total revenues** for the fiscal first quarter of 2027. The company provides agricultural biotechnology solutions, including high-oleic soybeans and related traits. Financial and operational updates highlight performance in its core seed and trait technologies.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) shareholders have experienced a **63% decline in share price** over the past three years. The stock has further fallen **58% in the last year**, reflecting ongoing challenges for long-term investors.
Bioceres Crop Solutions receives U.S. patent protection for its HB4 Wheat (IND-ØØ412-7), covering the first of four potential patents. The approval extends legal safeguards for the wheat variety and its production system until 2042, as granted by the USPTO. This marks a key milestone in the company’s efforts to commercialize the technology in the U.S. market.
The U.S. Department of Agriculture (USDA) removes regulatory restrictions on Bioceres Crop Solutions’ HB4 drought-tolerant wheat trait, easing its potential commercialization in the United States. The move follows Argentina-based Bioceres’ development of the trait to improve wheat resilience in water-scarce conditions. This deregulation could accelerate adoption by U.S. farmers seeking climate-adaptive crops.
Bioceres pursues regulatory approval in Australia to commercially plant its genetically modified (GMO) wheat variety. The company targets adoption amid rising food prices driven by the Ukraine war and climate-related crop risks. Bioceres positions its GMO wheat as a potential solution to global food security challenges.